We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can PG's Health Care Segment Extend Its Sales Momentum Ahead?
Read MoreHide Full Article
Key Takeaways
PG's premium brands face affordability pressures despite innovation-led growth and strong consumer loyalty.
Organic sales rose 4% in first-quarter fiscal 2027, driven by volume growth and favorable product mix.
PG balances premium innovation with value offerings like Charmin and Bounty Essentials amid rising costs.
The Procter & Gamble Company (PG - Free Report) , also known as P&G, is looking to sustain growth in its Health Care segment, supported by improving demand trends, portfolio expansion and efforts to strengthen consumer engagement. The company’s Health Care business, which includes Oral Care and Personal Health Care, continues to demonstrate resilience despite a challenging operating environment. In the first quarter of fiscal 2027, both categories recorded low-single-digit organic sales growth, contributing to the company’s broad-based revenue improvement. PG’s focus on product superiority, innovation and stronger retail execution remains central to sustaining momentum across its health-related categories.
A potential recovery in seasonal demand could provide an additional growth catalyst for the segment. Management highlighted that the Health Care business has faced headwinds from subdued cold and cough seasons over the past two years, which constrained category performance. However, recent weeks have witnessed an acceleration in cold and cough activity, raising expectations for improved demand for related health care products. If this trend persists, it could support stronger sales growth in Personal Health Care during the upcoming quarters. Meanwhile, P&G continues to emphasize consumer-focused innovation, improved product offerings and effective in-store execution to strengthen its competitive positioning and encourage repeat purchases.
Looking ahead, PG’s acquisition of Thorne, completed in early October 2026, presents an opportunity to strengthen its presence in the vitamins, minerals and supplements market. Management sees the potential to leverage P&G’s international reach, supply-chain capabilities and marketing expertise to support Thorne’s long-term expansion while preserving its existing operating strengths. However, broader category expansion remains a longer-term opportunity rather than an immediate growth driver. Management also identified a stronger cold and cough season as a potential catalyst for second-half growth. While uncertain seasonal demand and consumer spending pressures remain challenges, improving category trends and strategic portfolio investments could help PG’s Health Care segment sustain its sales momentum.
Are Peers, CHD and CL, Also Driving Health Care Growth?
Church & Dwight (CHD - Free Report) and Colgate-Palmolive Company (CL - Free Report) are leveraging product innovation, portfolio strength and strategic investments to drive growth across their health care categories.
Church & Dwight is strengthening its presence in the oral and personal health care categories through product innovation, portfolio optimization and targeted marketing investments. The company continues to benefit from strong consumer demand for its THERABREATH mouthwash and toothpaste and WATERPIK water flossers, which contributed to organic sales growth in the third quarter of 2026. Its SIMPLY SALINE nasal care products and HERO acne treatment portfolio also support its health and wellness offerings. CHD’s focus on expanding distribution, strengthening brand visibility and introducing consumer-focused innovations is expected to sustain demand across these categories. Continued momentum in oral care, coupled with improving household penetration and effective retail execution, could support the company’s sales growth in the coming quarters.
Colgate-Palmolive continues to leverage its strong oral care portfolio, product innovation and extensive global distribution network to sustain sales momentum. The company’s flagship Colgate brand benefits from its established presence across toothpaste, toothbrushes and other oral hygiene products, supported by consumers’ increasing focus on preventive dental care. In the third quarter of 2026, Colgate-Palmolive maintained its global leadership in toothpaste and manual toothbrushes, with year-to-date market shares of 41.4% and 33.1%, respectively. Its emphasis on premium offerings, science-backed innovation and effective brand-building initiatives is expected to strengthen consumer engagement and encourage trading up to higher-value products. Continued investments in product superiority, alongside opportunities in emerging markets, could support oral care demand and reinforce the company's long-term sales growth prospects.
PG’s Price Performance, Valuation & Estimates
P&G’s shares have gained 21.5% in the past six months compared with the industry’s 16.9% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 24.20X compared with the industry’s average of 21.18X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for P&G’s fiscal 2026 and 2027 EPS indicates year-over-year growth of 1.5% and 6.1%, respectively.
Image: Bigstock
Can PG's Health Care Segment Extend Its Sales Momentum Ahead?
Key Takeaways
The Procter & Gamble Company (PG - Free Report) , also known as P&G, is looking to sustain growth in its Health Care segment, supported by improving demand trends, portfolio expansion and efforts to strengthen consumer engagement. The company’s Health Care business, which includes Oral Care and Personal Health Care, continues to demonstrate resilience despite a challenging operating environment. In the first quarter of fiscal 2027, both categories recorded low-single-digit organic sales growth, contributing to the company’s broad-based revenue improvement. PG’s focus on product superiority, innovation and stronger retail execution remains central to sustaining momentum across its health-related categories.
A potential recovery in seasonal demand could provide an additional growth catalyst for the segment. Management highlighted that the Health Care business has faced headwinds from subdued cold and cough seasons over the past two years, which constrained category performance. However, recent weeks have witnessed an acceleration in cold and cough activity, raising expectations for improved demand for related health care products. If this trend persists, it could support stronger sales growth in Personal Health Care during the upcoming quarters. Meanwhile, P&G continues to emphasize consumer-focused innovation, improved product offerings and effective in-store execution to strengthen its competitive positioning and encourage repeat purchases.
Looking ahead, PG’s acquisition of Thorne, completed in early October 2026, presents an opportunity to strengthen its presence in the vitamins, minerals and supplements market. Management sees the potential to leverage P&G’s international reach, supply-chain capabilities and marketing expertise to support Thorne’s long-term expansion while preserving its existing operating strengths. However, broader category expansion remains a longer-term opportunity rather than an immediate growth driver. Management also identified a stronger cold and cough season as a potential catalyst for second-half growth. While uncertain seasonal demand and consumer spending pressures remain challenges, improving category trends and strategic portfolio investments could help PG’s Health Care segment sustain its sales momentum.
Are Peers, CHD and CL, Also Driving Health Care Growth?
Church & Dwight (CHD - Free Report) and Colgate-Palmolive Company (CL - Free Report) are leveraging product innovation, portfolio strength and strategic investments to drive growth across their health care categories.
Church & Dwight is strengthening its presence in the oral and personal health care categories through product innovation, portfolio optimization and targeted marketing investments. The company continues to benefit from strong consumer demand for its THERABREATH mouthwash and toothpaste and WATERPIK water flossers, which contributed to organic sales growth in the third quarter of 2026. Its SIMPLY SALINE nasal care products and HERO acne treatment portfolio also support its health and wellness offerings. CHD’s focus on expanding distribution, strengthening brand visibility and introducing consumer-focused innovations is expected to sustain demand across these categories. Continued momentum in oral care, coupled with improving household penetration and effective retail execution, could support the company’s sales growth in the coming quarters.
Colgate-Palmolive continues to leverage its strong oral care portfolio, product innovation and extensive global distribution network to sustain sales momentum. The company’s flagship Colgate brand benefits from its established presence across toothpaste, toothbrushes and other oral hygiene products, supported by consumers’ increasing focus on preventive dental care. In the third quarter of 2026, Colgate-Palmolive maintained its global leadership in toothpaste and manual toothbrushes, with year-to-date market shares of 41.4% and 33.1%, respectively. Its emphasis on premium offerings, science-backed innovation and effective brand-building initiatives is expected to strengthen consumer engagement and encourage trading up to higher-value products. Continued investments in product superiority, alongside opportunities in emerging markets, could support oral care demand and reinforce the company's long-term sales growth prospects.
PG’s Price Performance, Valuation & Estimates
P&G’s shares have gained 21.5% in the past six months compared with the industry’s 16.9% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 24.20X compared with the industry’s average of 21.18X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for P&G’s fiscal 2026 and 2027 EPS indicates year-over-year growth of 1.5% and 6.1%, respectively.
Image Source: Zacks Investment Research
PG stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.